Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats

Transplant International

Volumn 17, Issue 12, 2004, Pages 804-809

  Nowak, Grzegorz ^a   Norén, Ulf G ^a   Wernerson, Annika ^a   Marschall, Hanns Ulrich ^a   Möller, Lennart ^a   Ericzon, Bo Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ischaemia reperfusion injury; Liver perfusion; Liver transplantation; Ursodeoxycholic acid

Indexed keywords

BILE ACID; BILE SALT; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BILE FLOW; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CRYOPRESERVATION; LIVER CELL; LIVER HISTOLOGY; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 23944504082     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.tb00514.x     Document Type: Conference Paper

References (28)

1. Bzeizi KI, Jalan R, Plevris JN, et al. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transpl Surg 1997; 3:137.
2. Mueller AR, Platz KP, Schumacher G, et al. Mechanisms of preservation and reperfusion injury in human liver transplantation. Transplant Proc 1997; 29:3455.
3. Piratvisuth T, Tredger JM, Hayllar KA, et al. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg 1995; 1:296.
4. Rudi J, Schlenker T, Raedsch R, et al. Effect of ursodeoxycholic acid on biochemical parameters, hepatocyte proliferation and liver histology in galactosamine hepatitis in the rat. Res Exp Med 1995; 195:309.
5. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36:525.
6. Frezza EE, Gerunda GE, Plebani M, et al. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat. Dig Dis Sci 1993; 38:1291.
7. Hertl M, Harvey PR, Swanson PE, et al. Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts. Hepatology 1995; 21:1130.
8. Hertl M, Hertl MC, Kluth D, et al. Hydrophilic bile salts protect bile duct epithelium during cold preservation: a scanning electron microscopy study. Liver Transpl 2000; 6:207.
9. Rodrigues CM, Fan G, Ma X, et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998; 101:2790.
10. Rodrigues CM, Steer CJ. Bile acids and hepatocyte apoptosis: living/leaving life in the Fas lane. Gastroenterol 1999; 117:732.
11. Ishigami F, Naka S, Takeshita K, et al. Bile salt tauroursodeoxycholic acid modulation of Bax translocation to mitochondria protects the liver from warm ischemia-reperfusion injury in the rat. Transplantation 2001; 72:1803.
12. Natori S, Selzner M, Valentino KL, et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999; 68:89.
13. Parquet M, Rey C, Groussard M, et al. Pharmacokinetics and metabolism of [14C]ursodeoxycholic acid in the rat. Biochim Biophys Acta 1981; 665:299.
14. Beije B. The isolated perfused liver as a metabolizing system in mutagenicity testing. In: Kilbey BJ, Legator M, Nichols W, Ramel C, eds. Handbook of mutagenicity test procedures. Amsterdam, Elsevier, 1984:654.
15. Angelin B, Einarsson K, Leijd B. Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest 1979; 9:185.
16. Hasuike Y, Monden M, Valdivia LA, et al. A simple method for orthotopic liver transplantation with arterial reconstruction in rats. Transplantation 1998; 45:830.
17. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93:64.
18. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55:1265-1272.
19. Baron PW, Sindram D, Higdon D, et al. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation. Liver Transpl 2000; 6:407.
20. Purucker E, Marschall HU, Winograd R, et al. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats. Biochim Biophys Acta 2001; 1526:44.
21. Hertl M, Hertl MC, Kunkel P, et al. Tauroursodeoxycholate ameliorates reperfusion injury after pig liver transplantation. Transpl Int 1999; 12:454.
22. Falasca L, Tisone G, Palmieri G, Anselmo A, Di Paolo D, Baiocchi L, Torri E, Orlando G, Casciani CU, Angelico M. Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation 2001; 71:1268.
23. Ericzon BG. Early graft function in liver transplantation patients. Transplant Proc 1994; 26:3276.
24. Stiehl A, Raedsch R, Rudolph G. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology 1990; 98:424.
25. Hofmann AF. Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol Suppl 1994; 204:1.
26. Briceno J, Marchal T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002; 74:522.
27. Sundberg R, Alumets J, Ar'Rajab A, Ahren B, Bengmark S. Ultrastructure in liver preservation with Eurocollins and UW solutions. Transplant Proc 1990; 22:176.
28. Benz C, Angermuller S, Tox U, Kloters-Plachky P, Riedel HD, Sauer P, Stremmel W, Stiehl A. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol 1998; 28:99.